In the study by Slos et al., mastocytoma mice models were intratumorally administered with IL-2 encoding adenoviral vector, which resulted in increasing the levels of CD8+ cells and NK cells which consequently promotes tumor regression and survival (23). Here, CD8A is linked to neoplasm.